scholarly article | Q13442814 |
P50 | author | Chengqi Yi | Q56557284 |
P2093 | author name string | Chuan He | |
Jinghui Song | |||
Xushen Xiong | |||
Xiaoting Shu | |||
P2860 | cites work | Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins | Q27618787 |
Cellular processing of platinum anticancer drugs | Q29617899 | ||
DNA damage in the nucleosome core is refractory to repair by human excision nuclease | Q30969773 | ||
Circadian regulation of DNA excision repair: implications for chrono-chemotherapy | Q33438273 | ||
The effect of chromatin structure on cisplatin damage in intact human cells | Q33617354 | ||
Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent | Q33826103 | ||
Binding of kinetically inert metal ions to RNA: the case of platinum(II). | Q33842478 | ||
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance | Q35083535 | ||
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease | Q35852579 | ||
Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. | Q36127978 | ||
Direct cellular responses to platinum-induced DNA damage | Q36800400 | ||
Differential DNA lesion formation and repair in heterochromatin and euchromatin | Q37220505 | ||
DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells | Q37586327 | ||
HMGB proteins: interactions with DNA and chromatin | Q37685443 | ||
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance | Q37951497 | ||
Measurement of covalent drug-DNA interactions at the nucleotide level in cells at pharmacologically relevant doses | Q38298075 | ||
Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts | Q38329239 | ||
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin | Q38329454 | ||
Repair of cisplatin--DNA adducts by the mammalian excision nuclease | Q38354253 | ||
Nucleotide excision repair is impaired by binding of transcription factors to DNA. | Q39853410 | ||
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. | Q40320273 | ||
Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain. | Q42616061 | ||
3D-DIP-Chip: a microarray-based method to measure genomic DNA damage | Q43114888 | ||
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery | Q43638582 | ||
An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells | Q43888150 | ||
Nucleotide excision repair from site-specifically platinum-modified nucleosomes. | Q51836720 | ||
Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. | Q54111946 | ||
Structure, Recognition, and Processing of Cisplatin-DNA Adducts. | Q55035583 | ||
Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes | Q59058533 | ||
Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]] | Q69441288 | ||
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA | Q69586643 | ||
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation | Q93607580 | ||
P433 | issue | 46 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 14246-14249 | |
P577 | publication date | 2016-10-13 | |
P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
P1476 | title | Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale | |
P478 | volume | 55 |
Q64072657 | A Chemical Genetic Method for Monitoring Genome-Wide Dynamics of -GlcNAc Turnover on Chromatin-Associated Proteins |
Q45961755 | Chemical Analysis of DNA Damage. |
Q53836887 | Detecting Rare Mutations and DNA Damage with Sequencing-Based Methods. |
Q60907403 | Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs |
Q92043229 | Discovery of Cisplatin Binding to Thymine and Cytosine on a Single-Stranded Oligodeoxynucleotide by High Resolution FT-ICR Mass Spectrometry |
Q90617512 | Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines |
Q49962656 | Force spectroscopy unravels the role of ionic strength on DNA-cisplatin interaction: Modulating the binding parameters. |
Q90526979 | Genome-wide mapping of nucleotide excision repair with XR-seq |
Q47875319 | Genomic Studies Reveal New Aspects of the Biology of DNA Damaging Agents. |
Q89350394 | Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C |
Q90184738 | Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors |
Q89825438 | Methodologies for detecting environmentally induced DNA damage and repair |
Q39016146 | Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity |
Q90501007 | Sequence-Specific Quantitation of Mutagenic DNA Damage via Polymerase Amplification with an Artificial Nucleotide |
Q38716555 | Synthesis, Biological Evaluation, and Molecular Docking Studies on the DNA Binding Interactions of Platinum(II) Rollover Complexes Containing Phosphorus Donor Ligands. |